JP2018503685A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018503685A5 JP2018503685A5 JP2017556784A JP2017556784A JP2018503685A5 JP 2018503685 A5 JP2018503685 A5 JP 2018503685A5 JP 2017556784 A JP2017556784 A JP 2017556784A JP 2017556784 A JP2017556784 A JP 2017556784A JP 2018503685 A5 JP2018503685 A5 JP 2018503685A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- net
- inhibitor
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562105342P | 2015-01-20 | 2015-01-20 | |
| US62/105,342 | 2015-01-20 | ||
| PCT/US2016/013847 WO2016118476A1 (en) | 2015-01-20 | 2016-01-19 | Anti-net compounds for treating and preventing fibrosis and for facilitating wound healing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018503685A JP2018503685A (ja) | 2018-02-08 |
| JP2018503685A5 true JP2018503685A5 (https=) | 2019-02-21 |
Family
ID=56417634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017556784A Pending JP2018503685A (ja) | 2015-01-20 | 2016-01-19 | 線維化を処置および予防するためのならびに創傷治癒を促進するための抗ｎｅｔ化合物 |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US11400139B2 (https=) |
| EP (2) | EP3797789B1 (https=) |
| JP (1) | JP2018503685A (https=) |
| CA (1) | CA2974369A1 (https=) |
| WO (1) | WO2016118476A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3351263A1 (en) * | 2017-01-20 | 2018-07-25 | Universitätsklinikum Hamburg-Eppendorf | Pharmaceutical preparation for treating or preventing tissue adhesion |
| EP3668972B8 (en) | 2017-08-18 | 2024-11-13 | Neutrolis, Inc. | Engineered dnase enzymes and use in therapy |
| EP3761971A4 (en) * | 2018-03-09 | 2021-11-10 | The University of Memphis Research Foundation | FLAMMATION INHIBITION COMPOSITIONS AND METHODS |
| US12480150B2 (en) | 2018-06-29 | 2025-11-25 | Viktor Veniaminovich Tets and Georgy Viktorovich TETS | Compositions for modulating gut microbiota |
| MX2022002760A (es) | 2019-09-06 | 2022-04-06 | Consejo Nacional De Investigaciones Cientificas Y Tecn | Una composicion farmaceutica para el tratamiento topico de heridas. |
| GB202012326D0 (en) * | 2020-08-07 | 2020-09-23 | Citryll B V | Diagnostic |
| CN113358872B (zh) * | 2021-06-03 | 2022-10-21 | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 用于评估肿瘤免疫治疗疗效的标志物组及系统 |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3270960A (en) | 1964-09-11 | 1966-09-06 | Sperry Rand Corp | Fluid sensor |
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4534899A (en) | 1981-07-20 | 1985-08-13 | Lipid Specialties, Inc. | Synthetic phospholipid compounds |
| US4426330A (en) | 1981-07-20 | 1984-01-17 | Lipid Specialties, Inc. | Synthetic phospholipid compounds |
| US4920016A (en) | 1986-12-24 | 1990-04-24 | Linear Technology, Inc. | Liposomes with enhanced circulation time |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US6919320B1 (en) * | 1987-10-28 | 2005-07-19 | Wellstat Therapeutics Corporation | Pharmaceutical compositions containing deoxyribonucleosides for wound healing |
| GB8824593D0 (en) | 1988-10-20 | 1988-11-23 | Royal Free Hosp School Med | Liposomes |
| ATE176924T1 (de) | 1988-12-23 | 1999-03-15 | Genentech Inc | Verfahren zur herstellung von menschlicher dnase |
| DE3903672C1 (https=) | 1989-02-08 | 1990-02-01 | Lohmann Gmbh & Co Kg | |
| US5356633A (en) | 1989-10-20 | 1994-10-18 | Liposome Technology, Inc. | Method of treatment of inflamed tissues |
| US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US5225212A (en) | 1989-10-20 | 1993-07-06 | Liposome Technology, Inc. | Microreservoir liposome composition and method |
| US5665710A (en) | 1990-04-30 | 1997-09-09 | Georgetown University | Method of making liposomal oligodeoxynucleotide compositions |
| JP3220180B2 (ja) | 1991-05-23 | 2001-10-22 | 三菱化学株式会社 | 薬剤含有タンパク質結合リポソーム |
| JP3351476B2 (ja) | 1993-01-22 | 2002-11-25 | 三菱化学株式会社 | リン脂質誘導体及びそれを含有するリポソーム |
| US5395619A (en) | 1993-03-03 | 1995-03-07 | Liposome Technology, Inc. | Lipid-polymer conjugates and liposomes |
| US6191105B1 (en) | 1993-05-10 | 2001-02-20 | Protein Delivery, Inc. | Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin |
| US5540935A (en) | 1993-12-06 | 1996-07-30 | Nof Corporation | Reactive vesicle and functional substance-fixed vesicle |
| US5543152A (en) | 1994-06-20 | 1996-08-06 | Inex Pharmaceuticals Corporation | Sphingosomes for enhanced drug delivery |
| US5820873A (en) | 1994-09-30 | 1998-10-13 | The University Of British Columbia | Polyethylene glycol modified ceramide lipids and liposome uses thereof |
| US5756122A (en) | 1995-06-07 | 1998-05-26 | Georgetown University | Liposomally encapsulated nucleic acids having high entrapment efficiencies, method of manufacturer and use thereof for transfection of targeted cells |
| US5539878A (en) | 1995-06-16 | 1996-07-23 | Elonex Technologies, Inc. | Parallel testing of CPU cache and instruction units |
| US5858397A (en) | 1995-10-11 | 1999-01-12 | University Of British Columbia | Liposomal formulations of mitoxantrone |
| US5858401A (en) | 1996-01-22 | 1999-01-12 | Sidmak Laboratories, Inc. | Pharmaceutical composition for cyclosporines |
| JP3756313B2 (ja) | 1997-03-07 | 2006-03-15 | 武 今西 | 新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体 |
| DE69834038D1 (de) | 1997-07-01 | 2006-05-18 | Isis Pharmaceutical Inc | Zusammensetzungen und verfahren zur verabreichung von oligonukleotiden über die speiseröhre |
| JP2002537343A (ja) | 1999-02-23 | 2002-11-05 | アイシス・ファーマシューティカルス・インコーポレーテッド | 多重粒子製剤 |
| IT1318539B1 (it) | 2000-05-26 | 2003-08-27 | Italfarmaco Spa | Composizioni farmaceutiche a rilascio prolungato per lasomministrazione parenterale di sostanze idrofile biologicamente |
| US7063860B2 (en) | 2001-08-13 | 2006-06-20 | University Of Pittsburgh | Application of lipid vehicles and use for drug delivery |
| WO2005075414A1 (ja) | 2004-02-04 | 2005-08-18 | Yokohama City University | ぺプチジルアルギニンデイミナーゼ４阻害剤 |
| US20070213292A1 (en) | 2005-08-10 | 2007-09-13 | The Rockefeller University | Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof |
| US7964636B2 (en) | 2005-11-07 | 2011-06-21 | University Of South Carolina | Synthesis and use of novel inhibitors and inactivators of protein arginine deiminases |
| US8617542B2 (en) | 2008-04-03 | 2013-12-31 | Kane Biotech Inc. | DispersinB™, 5-fluorouracil, deoxyribonuclease I and proteinase K-based antibiofilm compositions and uses thereof |
| AU2009270003A1 (en) | 2008-06-16 | 2010-01-14 | Academisch Ziekenhuis Leiden H.O.D.N. Lumc | Peptidylarginine deiminase (PAD) inhibitors |
| WO2012166611A2 (en) * | 2011-05-27 | 2012-12-06 | Immune Disease Institute, Inc. | Methods for treating and preventing neutrophil-derived net toxicity and thrombosis |
| EP2775304A1 (en) * | 2013-03-07 | 2014-09-10 | Universitätsspital Basel | Methods for detecting inflammatory disorder |
| EP3017824B1 (en) * | 2013-04-09 | 2019-06-05 | The University of Tokyo | Inhibitor of extracellular trap formation in leukocytes |
| GB201309180D0 (en) | 2013-05-21 | 2013-07-03 | Ucl Business Plc | Compounds and Their Uses |
| CN105358187B (zh) * | 2013-06-24 | 2018-06-22 | 登士伯Ih有限公司 | 包含胶原-vi的医疗装置 |
-
2016
- 2016-01-19 EP EP20187049.0A patent/EP3797789B1/en active Active
- 2016-01-19 EP EP16740569.5A patent/EP3247386A4/en not_active Withdrawn
- 2016-01-19 JP JP2017556784A patent/JP2018503685A/ja active Pending
- 2016-01-19 CA CA2974369A patent/CA2974369A1/en not_active Abandoned
- 2016-01-19 US US15/544,618 patent/US11400139B2/en active Active
- 2016-01-19 WO PCT/US2016/013847 patent/WO2016118476A1/en not_active Ceased
-
2022
- 2022-06-24 US US17/848,998 patent/US20230190886A1/en not_active Abandoned
-
2025
- 2025-03-26 US US19/091,081 patent/US20250242000A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018503685A5 (https=) | ||
| Neckers et al. | Methods to validate Hsp90 inhibitor specificity, to identify off-target effects, and to rethink approaches for further clinical development | |
| EP4230623A3 (en) | Pyridine compounds as allosteric shp2 inhibitors | |
| EA201790124A1 (ru) | Соли берберина, соли урсодезоксихолевой кислоты и их комбинации, способы получения и применения | |
| CN111868056A (zh) | 1,2,4-噁二唑类化合物及其制备方法和医药用途 | |
| JP2007523049A5 (https=) | ||
| WO2006014353A3 (en) | Glycogen or polysaccharide storage disease treatment method | |
| WO2006037031A3 (en) | Formulations and methods for treatment of inflammatory diseases | |
| RU2018121036A (ru) | Комбинированная пре- и пробиотическая композиция | |
| WO2011116026A3 (en) | Inhibitors of beta integrin-g protein alpha subunit binding interactions | |
| RU2018124487A (ru) | Лечение внутрипеченочного холестаза и родственных заболеваний печени | |
| MX2021000340A (es) | Nuevos compuestos. | |
| WO2009004995A1 (ja) | 生理活性物質を定着および発現させる方法 | |
| EP4410833A3 (en) | Compositions and methods for treating fatty tissue buildup | |
| Garrido et al. | Medical course and complications after lung transplantation | |
| CY1125769T1 (el) | Φαρμακευτικοι συνδυασμοι που περιεχουν εναν αναστολεα αποακετυλασης ιστονων και εναν αναστολεα bcl-2 και μεθοδοι χρησης αυτων | |
| JP2021514365A5 (https=) | ||
| JP2017536380A5 (https=) | ||
| JP2019533715A5 (https=) | ||
| JP2020523375A5 (https=) | ||
| JP2020527138A5 (https=) | ||
| WO2020060779A3 (en) | Methods and compositions for treating laminopathies affecting skeletal or cardiac muscle | |
| Chen et al. | New options for pneumothorax management | |
| EA201792565A1 (ru) | Бисамидное производное дикарбоновой кислоты в качестве средства, стимулирующего регенерацию тканей и восстановление сниженных функций тканей | |
| EA202090705A1 (ru) | Способы и композиции, предназначенные для лечения хронических заболеваний легких |